The results from MCF7 and MDA-MB-231 cells argues for Ago2 downregulation as a mechanism to lower the effectiveness of the miRNA machinery in aggressive breast cancer cells resulting in increased STIM1 expression to support cell migration. This evidence concerns the gene AGO2 and breast cancer.